Aimee Campbell, PhD, MSW

Member, StAD core
Associate Professor of Clinical Psychiatric Social Work, Research Scientist
, Columbia University Medical Center

Phone: 646-774-6138

Dr. Campbell’s research focuses on the development and testing of individual and program level interventions for substance use disorders and HIV prevention and treatment, including the leveraging of technology-based platforms, with the objective of increasing adoption and implementation of science-based treatments. Dr. Campbell co-led, with Dr. Edward Nunes, one of the largest multi-site randomized controlled trials of a technology based intervention for substance use disorders, resulting in the first FDA clearance of a digital therapeutic. Her current clinical research includes NIDA-funded projects to test an adapted technology-based intervention with American Indian/Alaska Native addiction treatment seekers, an implementation evaluation of the universal antiretroviral treatment guidelines among individuals with HIV and problem substance use, and a randomized trial of enhanced naloxone training (PI Sandra Comer) for which Dr. Campbell is directing a qualitative sub-study of participants involved in opioid overdose reversals. Dr. Campbell is also a key collaborator in two SAMHSA-funded initiatives to 1) develop and evaluate an implementation support pilot program for the integration of addiction treatment into primary care and 2) support the national implementation facilitation technical assistance component of the recently funded “STR TA” grant to support states combatting the opioid epidemic. Dr. Campbell received her PhD in 2009 from Columbia University School of Social Work.


University of Washington, Seattle, WA
BA - 1995 - Sociology

Columbia University, New York, NY
MSSW - 2003 - Social Work
MPhil - 2009 - Social Work
PhD - 2009 - Social Work